Analyst Ranking
Bottom 6%
#5068 out of 5342 analysts
Average Return
-2.42%
Win Rate
44%61 out of 140
Risk vs Reward
Poor
Good

Brandon Folkes's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Connect Biopharma Holdings LtdCNTB
+147.06%$0.85$2.10
2025-06-12 -
2026-06-11
Buy
Trevi Therapeutics IncTRVI
+130.83%$6.26$14.45
2025-05-28 -
2026-05-27
Buy
Elutia IncELUT
+130.77%$1.43$3.30
2023-08-15 -
2024-08-14
Strong Buy
Achieve Life Sciences IncACHV
+127.66%$2.82$6.42
2026-03-25 -
2026-07-31
Buy
Trevi Therapeutics IncTRVI
+122.74%$2.77$6.17
2024-06-13 -
2025-06-12
Strong Buy

Brandon Folkes Analyst Color

Get additional color on Brandon Folkes's coverage of popular stocks

Brandon Folkes's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Polypid LtdPYPD
6Buy$13.00+203.03%Reiterates
11 days ago
Trevi Therapeutics IncTRVI
6Buy$24.00+31.51%Maintains
12 days ago
Cardiol Therapeutics IncCRDL
4Buy$9.00+608.66%Reiterates
18 days ago
Omeros CorpOMER
6Buy$33.00+178.72%Maintains
a month ago
Connect Biopharma Holdings LtdCNTB
3Buy$7.00+246.53%Reiterates
a month ago
Zevra Therapeutics IncZVRA
2Buy$26.00+173.40%Reiterates
a month ago
Enanta Pharmaceuticals IncENTA
4Buy$20.00+58.73%Reiterates
a month ago
Achieve Life Sciences IncACHV
5Buy$12.00+86.92%Reiterates
a month ago
Traws Pharma IncTRAW
3Hold$1.00+122.22%Downgrades
a month ago
Talphera IncTLPH
1Buy$3.00+134.38%Assumes
2 months ago
Heron Therapeutics IncHRTX
4Buy$2.00+303.23%Maintains
2 months ago
Rein Therapeutics IncRNTX
2Buy$8.00+985.48%Maintains
2 months ago
Sintx Technologies IncSINT
2Buy$10.00+488.24%Reiterates
2 months ago
Mannkind CorpMNKD
10Buy$10.00+155.75%Maintains
3 months ago
Eupraxia Pharmaceuticals IncEPRX
7Buy$11.00+71.88%Reiterates
3 months ago
Rani Therapeutics Holdings IncRANI
5Buy$11.00+1,321.19%Reiterates
4 months ago
Journey Medical CorpDERM
3Buy$13.00+104.08%Reiterates
4 months ago
Collegium Pharmaceutical IncCOLL
7Buy$60.00+69.54%Reiterates
4 months ago
Pelthos Therapeutics IncPTHS
2Buy$60.00+109.35%Reiterates
4 months ago
Sagimet Biosciences IncSGMT
3Buy$29.00+307.88%Reiterates
5 months ago
Xeris Biopharma Holdings IncXERS
5Buy$10.00+23.76%Reiterates
5 months ago
Cormedix IncCRMD
5Buy$13.00+72.64%Maintains
6 months ago
Indivior Pharmaceuticals IncINDV
3Buy$48.00+19.97%Maintains
7 months ago
Milestone Pharmaceuticals IncMIST
4Buy$8.00+620.72%Reiterates
7 months ago
Genfit SaGNFTY
2Buy$7.00+44.33%Maintains
10 months ago
Ani Pharmaceuticals IncANIP
5Buy$121.00+52.70%Maintains
10 months ago
Valneva SeVALN
2Buy$18.00+262.17%Reiterates
a year ago
Rockwell Medical IncRMTI
1Strong Buy$50.00N/AInitiates Coverage On
2 years ago
Adial Pharmaceuticals IncADIL
1Strong Buy$200.00N/AInitiates Coverage On
2 years ago
Emergent Biosolutions IncEBS
4Strong Buy$16.00N/AReiterates
2 years ago
Scilex Holding CoSCLX
1Strong Buy$455.00N/AInitiates Coverage On
2 years ago
Sanara Medtech IncSMTI
4Strong Buy$59.00N/AReiterates
3 years ago
Jazz Pharmaceuticals PLCJAZZ
2Strong Buy$180.00N/AReiterates
3 years ago
Elutia IncELUT
3Strong Buy$8.00N/AReiterates
3 years ago
Amryt Pharma PLCAMYT
2Hold$14.75N/ADowngrades
4 years ago
Veru IncVERU
3Strong Buy$220.00N/AMaintains
4 years ago
Sorrento Therapeutics IncSRNEQ
1Strong Buy$5.00N/AInitiates Coverage On
4 years ago
Obseva SaOBSVF
1Strong Buy$6.00N/AInitiates Coverage On
4 years ago
Alkermes PLCALKS
1Strong Buy$32.00N/AUpgrades
5 years ago
IMV IncIMVIQ
1Strong Buy$40.00N/AInitiates Coverage On
5 years ago
Redhill Biopharma LtdRDHL
1Strong Buy$22,000.00N/AInitiates Coverage On
5 years ago
Trevena IncTRVN
1Strong Buy$3,125.00N/AInitiates Coverage On
6 years ago
Optinose IncOPTN
3Strong Buy$315.00N/AReiterates
6 years ago
Eagle Pharmaceuticals IncEGRX
2Hold$46.00N/AMaintains
6 years ago
Momenta Pharmaceuticals IncMNTA
1Hold$30.00N/AReiterates
6 years ago
Opiant Pharmaceuticals IncOPNT
1Strong Buy$42.00N/AMaintains
8 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
1Strong Buy$50.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.